As of Oct 20
| -0.13 / -4.87%|
The 1 analysts offering 12-month price forecasts for Benitec Biopharma Ltd have a median target of 5.19, with a high estimate of 5.19 and a low estimate of 5.19. The median estimate represents a +104.17% increase from the last price of 2.54.
The current consensus among 1 polled investment analysts is to Hold stock in Benitec Biopharma Ltd. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.